Our blog

Will Covid-19 increase US biosimilar adoption in 2021?
Will Covid-19 increase US biosimilar adoption in 2021?
by Christine Sands
Posted in Biopharma
In 2019, the US biosimilar market was worth $737.2 million and continues to grow with a CAGR of 46.2% forecast for 2020-2027, however many are frustrated at the current rate of adoption in the US. But with increasing healthcare costs and a growing debt from Covid-19, what does the next year hold for biosimilar adoption across the US?
Read more
Interview with Dr Melissa Toyos | MD Partner | Toyos Clinic
Interview with Dr Melissa Toyos | MD Partner | Toyos Clinic
by Tanya Ridding
Posted in MedTech & Devices
As part of our ‘Female Leaders: Inspiring Together' series, we interviewed Dr Melissa Toyos – MD Partner of Toyos Clinic – about her career journey as an ophthalmic surgeon and why managing work-life balance means accepting you can't do everything.
Read more
Interview with Rachel McNeill | Founder & CEO | PharmaPhix
Interview with Rachel McNeill | Founder & CEO | PharmaPhix
by Christine Sands
Posted in Biopharma
As part of our ‘Female Leaders: Inspiring Together’ series, we interviewed Rachel McNeill – Founder & CEO at PharmaPhix – about her new pharma services company and why she feels society’s biggest challenge is accepting that we all have an equal role in balancing work and family life regardless of gender.
Read more